1. Home
  2. ADCT vs RMAX Comparison

ADCT vs RMAX Comparison

Compare ADCT & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • RMAX
  • Stock Information
  • Founded
  • ADCT 2011
  • RMAX 1973
  • Country
  • ADCT Switzerland
  • RMAX United States
  • Employees
  • ADCT N/A
  • RMAX N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • RMAX Real Estate
  • Sector
  • ADCT Health Care
  • RMAX Finance
  • Exchange
  • ADCT Nasdaq
  • RMAX Nasdaq
  • Market Cap
  • ADCT 143.1M
  • RMAX 161.9M
  • IPO Year
  • ADCT 2020
  • RMAX 2013
  • Fundamental
  • Price
  • ADCT $1.49
  • RMAX $8.55
  • Analyst Decision
  • ADCT Strong Buy
  • RMAX Sell
  • Analyst Count
  • ADCT 5
  • RMAX 2
  • Target Price
  • ADCT $8.50
  • RMAX $8.75
  • AVG Volume (30 Days)
  • ADCT 344.2K
  • RMAX 168.0K
  • Earning Date
  • ADCT 03-27-2025
  • RMAX 05-01-2025
  • Dividend Yield
  • ADCT N/A
  • RMAX N/A
  • EPS Growth
  • ADCT N/A
  • RMAX N/A
  • EPS
  • ADCT N/A
  • RMAX 0.37
  • Revenue
  • ADCT $70,837,000.00
  • RMAX $307,685,000.00
  • Revenue This Year
  • ADCT $6.81
  • RMAX N/A
  • Revenue Next Year
  • ADCT $11.24
  • RMAX $1.25
  • P/E Ratio
  • ADCT N/A
  • RMAX $22.96
  • Revenue Growth
  • ADCT 1.84
  • RMAX N/A
  • 52 Week Low
  • ADCT $1.39
  • RMAX $6.94
  • 52 Week High
  • ADCT $5.38
  • RMAX $14.31
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 39.46
  • RMAX 40.38
  • Support Level
  • ADCT $1.41
  • RMAX $8.74
  • Resistance Level
  • ADCT $1.68
  • RMAX $9.39
  • Average True Range (ATR)
  • ADCT 0.12
  • RMAX 0.36
  • MACD
  • ADCT -0.03
  • RMAX 0.04
  • Stochastic Oscillator
  • ADCT 16.00
  • RMAX 26.32

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

About RMAX RE/MAX Holdings Inc.

RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.

Share on Social Networks: